BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AC-101 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AC-101\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07755241-60@assetmemo.bio
DTSTAMP:20261121T004020Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:AC-101: Phase 2 readout est. (NCT07755241)
DESCRIPTION:AC-101\, phase 2\, Ulcerative Colitis.\nStudy: A Study of AC-10
 1 Tablets in Patients With Ulcerative Colitis\nEstimated primary completio
 n: 30 November 2027. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 ac-101#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07755241
URL:https://assetmemo.bio/drug/ac-101#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
